Japan gov't panel OKs Pfizer's COVID vaccine for children aged 5-11

A Japanese health ministry panel approved Thursday the administration of Pfizer Inc.'s coronavirus vaccine to children aged 5 to 11, making it the first in Japan to be available for the age group.Around 7 million children will be eligible to receive the COVID-19 vaccine from March at the earliest once it is granted special approval by the Ministry of Health, Labor and Welfare.The U.S. pharmaceutical giant and its German partner BioNTech SE applied last November for Japanese government approval to inoculate children aged 5 to 11 with their jointly developed vaccine.Their vaccine is currently…READ FULL ARTICLE